Skip to main content
. 2021 May 11;16(5):e0251289. doi: 10.1371/journal.pone.0251289

Table 4. Clinical characteristics of Chiari1000 and Duke subjects.

Chiari 1000 (N = 94) Duke (N = 92)
Number % Number %
CTD+ 28 29.79 53 57.61
CTD- 66 70.21 27 29.35
Unknown CTD 12 13.04
EDS- 89 94.68 87 94.57
EDS+ 5 5.32 5 5.43
Syringomyelia 14 14.89 22 23.91
No syringomyelia 80 85.11 70 76.09